Clinical Trial

Enhancing the Efficacy and Tolerability of Metformin by add-on Polyherbal Formulation: a Gut Microbiome Study

Study acronym: Metherb
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Study population: Type 2 diabetes patients Design of the study: Randomized, two-arm, placebo-controlled, and prospective crossover cohort study. Objective: To evaluate the effects of interactions between metformin and traditionally used polyherbal formulations on gut microbiota in a prospective crossover study involving type 2 diabetes mellitus patients. Sample size: 66 patients. Duration of study: 06/2024 - 12/2026
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-20.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-07-16
Trial Details
NCT Number NCT06846138
Lead Sponsor Pauls Stradins Clinical University Hospital
Conditions Diabetes Mellitus Type 2
Enrollment 66 participants
Start Date 2025-03-01
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-17